Carbapenemase-producing Enterobacteriaceae continue to spread in Europe
Carbapenemase-producing Enterobacteriaceae (CPE) are an emerging threat to healthcare. Beside the carbapenems – a last-line class of antibiotics – CPE are resistant to most other antibiotics, leaving few options for the treatment of infected patients. In an effort to assess the nature and scale of CPE spread in Europe, a group of European experts is implementing the European Survey on Carbapenemase-Producing Enterobacteriaceae (EuSCAPE).
Second European HIV testing week kicks off today
From 21 to 28 November 2014, nearly 700 organisations across Europe will host activities to increase awareness of the personal and public health benefits of HIV testing. As HIV infection can remain asymptomatic for a long time and a substantial number of infected persons across Europe are unaware of their infection, ECDC supports the aims of this second European HIV testing week.
Moving towards better global foodborne disease surveillance
Almost 1 in 10 people worldwide fall ill every year after eating contaminated food which commonly causes bacterial diarrhoea, resulting in 230 000 deaths each year.
Epidemiological update: Multi-country outbreak of Salmonella Enteritidis phage type 8, MLVA profile 2-9-7-3-2 and 2-9-6-3-2 infections
Since the ECDC and EFSA joint rapid outbreak assessment was published on 7 March 2017, six EU Member States (Belgium, France, Italy, Norway, Sweden and the United Kingdom) have reported 50 confirmed and 12 probable new cases associated with the multi-country outbreak of Salmonella Enteritidis phage type 8 infections (MLVA profiles 2-9-7-3-2 and 2-9-6-3-2) ongoing in the EU/EEA. In addition, twelve probable cases have been reclassified as confirmed.
Gonorrhoea strains across Europe becoming more susceptible to main treatment options
According to test results from the annual European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP), resistance levels to the main antimicrobials used for treatment of gonorrhoea infection have seen an encouraging decrease since 2010.
Epidemiological update: multi-country outbreak of Salmonella Enteritidis with MLVA profile 2-9-7-3-2 or 2-9-6-3-2 infections
Since the previous ECDC epidemiological update was published on 30 June 2017, seven EU/EEA countries (Belgium, France, Luxembourg, the Netherlands, Norway, Sweden and the United Kingdom) have reported 96 confirmed and 34 probable new cases associated with the multi-country outbreak of Salmonella Enteritidis with MLVA profiles 2-9-7-3-2 or 2-9-6-3-2 ongoing in the EU/EEA.
1st Hepatitis E virus network (HEVnet) meeting
The key objective of this meeting was to verify the rationale and objectives of molecular typing for surveillance of hepatitis E virus (HEV) through the hepatitis E network (HEVnet). The workshop reviewed HEVnet as a tool for molecular surveillance of HEV in Europe.
European laboratories move forward towards stronger epidemic readiness for infectious disease threats.
The latest EULabCap data on assessing the public health laboratory capacities among 30 EU and EEA countries in 2016 reveal continuous improvement in reducing inequalities, with ten more countries reaching fair to high capability levels over the 4 years of monitoring.